In a study on the comprehensive molecular characterization of PRCC, alteration of the MET gene (mutation, splice variant, or gene fusion) or gain of chromosome 7 copy number was identified in 81.3% of Type 1 tumor.38 This evidence concerns the gene PRCC and neoplasm.